Lu Alleruzzo, CEO and David Anderson, PhD, CSO of Immunophotonics, are excited to participate in the NCI SBIR Peer Learning...

Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking...

Congratulations to Professor Wei Chen and his lab University of Oklahoma for their publication titled “Localized ablative immunotherapy enhances antitumor...

Siu Kit “Samuel” Lam, PhD, Senior Vice President of Science & Research at Immunophotonics, Inc. attended the SITC Immuno-Oncology Drug...

Immunophotonics wants to congratulate Professor Wei Chen and his lab University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K....

Immunophotonics is pioneering the field of Interventional Immunology-Oncology™, where a single injection of IP-001 --seamlessly integrated into the clinical workflow--...

Immunophotonics co-founders Lu Alleruzzo (CEO), Tomas Hode, PhD (CIO and President), and David Anderson, PhD (CSO) are excited to be...

Immunophotonics won the Startup World Cup St. Louis Regional finals. A big thank you to Emily Hemingway and her team...

We are thrilled to announce that Dr. Robert Martin has successfully enrolled and treated the first patient in our groundbreaking...

Immunophotonics is excited to share that Wei Chen, co-inventor of IP-001, Stephenson Chair, professor and interim director of the Stephenson...